Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Jiangsu Chia Tai Tianqing Pharmaceutical Group patents boric acid derivatives

Feb. 25, 2020

Phase II results for olaparib with or without cediranib in mCRPC

Feb. 25, 2020

Zebrafish embryos xenografted with ACC cells to study antitumor effects of abiraterone acetate

Feb. 25, 2020

Artios Pharma synthesizes DNA polymerase inhibitors

Feb. 24, 2020

Sumitomo Dainippon Pharma discovers MEN1/KMT2A interaction inhibitors

Feb. 24, 2020

GlaxoSmithKline presents new ATF-4 inhibitors

Feb. 24, 2020

Incyte patents new hSTING receptor agonists

Feb. 24, 2020

FDA grants IND approval for Veyonda plus doxorubicin in soft tissue sarcomas

Feb. 24, 2020

Novel genetically engineered murine model of SCBC

Feb. 24, 2020

Revlimid capsules granted additional approval in Japan

Feb. 24, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...